Ascentage Pharma Group InternationalAscentage Pharma Group International - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Check the end of this webpage for potential risks for Ascentage Pharma Group International based on industry, geography and marketcap. This analysis of Ascentage Pharma Group International is assembled by All Street Sevva using leading AI. This webpage is a zero-cost E,S&G report covering Ascentage Pharma Group International.

Ascentage Pharma Group International in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.7; made up of an environmental score of 8.0, social score of 8.0 and governance score of 4.0.

SDG Transparency Score for Ascentage Pharma Group International 
Low
0 - 3

6.7

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Ascentage Pharma Group International 
8.0

Environmental

8.0

Social

4.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
432Twist Bioscience Corp
6.8
High
432Rhythm Pharmaceuticals Inc
6.8
High
446Ascentage Pharma Group International
6.7
High
446Actinium Pharmaceuticals Inc
6.7
High
446AnGes Inc
6.7
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Ascentage Pharma Group International have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Ascentage Pharma Group International disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Ascentage Pharma Group International report the average age of the workforce?

LockedSign up for free to unlock

Does Ascentage Pharma Group International reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Ascentage Pharma Group International disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Ascentage Pharma Group International disclose cybersecurity risks?

LockedSign up for free to unlock

Does Ascentage Pharma Group International offer flexible work?

LockedSign up for free to unlock

Does Ascentage Pharma Group International have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Ascentage Pharma Group International disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Ascentage Pharma Group International conduct supply chain audits?

LockedSign up for free to unlock

Does Ascentage Pharma Group International disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Ascentage Pharma Group International conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Ascentage Pharma Group International disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Ascentage Pharma Group International disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Ascentage Pharma Group International disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Ascentage Pharma Group International disclose water use targets?

LockedSign up for free to unlock

Does Ascentage Pharma Group International have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Ascentage Pharma Group International have a product recall in the last two years?

LockedSign up for free to unlock

Does Ascentage Pharma Group International disclose incidents of discrimination?

LockedSign up for free to unlock

Does Ascentage Pharma Group International allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Ascentage Pharma Group International issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Ascentage Pharma Group International disclose parental leave metrics?

LockedSign up for free to unlock

Does Ascentage Pharma Group International disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Ascentage Pharma Group International disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Ascentage Pharma Group International disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Ascentage Pharma Group International support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Ascentage Pharma Group International disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Ascentage Pharma Group International reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Ascentage Pharma Group International involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Ascentage Pharma Group International disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Ascentage Pharma Group International disclose its waste policy?

LockedSign up for free to unlock

Does Ascentage Pharma Group International report according to TCFD requirements?

LockedSign up for free to unlock

Does Ascentage Pharma Group International disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Ascentage Pharma Group International disclose energy use targets?

LockedSign up for free to unlock

Does Ascentage Pharma Group International disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Ascentage Pharma Group International have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Ascentage Pharma Group International
These potential risks are based on the size, segment and geographies of the company.

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation, as well as for patients with tyrosine kinase inhibitor resistant chronic phase chronic myeloid leukemia. It also has APG-2575, an orally administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors, which is under Phase Ib/II clinical study; APG-115, an oral small molecule inhibitor of the MDM2-p53 protein-protein interaction for treating solid tumors and hematological malignancies; and APG-1387, a small molecule inhibitor of apoptosis proteins for advanced solid tumors and chronic HBV infection. In addition, it is involved in the development of APG-1252, a small molecule drug to restore apoptosis through selective inhibition of the Bcl-2 and Bcl-xL proteins for SCLC, lymphoma, and other solid tumors; APG-2449 for non-small-cell lung carcinoma; APG-5918, an orally available and selective EED inhibitor with a best-in-class potential that is under pre-clinical stage; APG-265, which is in the IND-enabling stage for hematological malignancies and solid tumors; and UBX1967/1325 targeting Bcl family indicated for DME that is under Phase II development. Ascentage Pharma Group International has collaboration relationships with major biotechnology and pharmaceutical companies, and academic institutions, which include Innovent Biologics, Inc.; National Cancer Institute; Pfizer Inc.; and Clover Biopharmaceuticals (Hong Kong) Co., Limited. The company was founded in 2009 and is headquartered in Suzhou, China.

Sorry!

Failed to process!